| Literature DB >> 22169395 |
Stéphanie Millecamps1, Philippe Corcia, Cécile Cazeneuve, Séverine Boillée, Danielle Seilhean, Véronique Danel-Brunaud, Nadia Vandenberghe, Pierre-François Pradat, Nadine Le Forestier, Lucette Lacomblez, Gaëlle Bruneteau, William Camu, Alexis Brice, Vincent Meininger, Eric LeGuern, François Salachas.
Abstract
Mutations in UBQLN2 encoding ubiquilin-2 have recently been identified in families with dominant X-linked juvenile and adult-onset amyotrophic lateral sclerosis (ALS) and ALS/dementia. Ubiquilin-2 is a component of the ubiquitin inclusions detected in degenerating neurons in ALS patients. All the previously reported UBQLN2 mutations were localized in 1 of the 12 PXX domains of ubiquilin-2 protein. We sequenced UBQLN2 in 130 French patients with familial ALS (FALS) and absence of male-to-male transmission and the PXX domain in 240 more patients with sporadic ALS (SALS). We identified, at the heterozygote state, the c.1500_1508delCATAGGCCC, p.Gly502_Ile504del, in 1 affected woman. This deletion presumably leads to the in-frame deletion of 1 PXX repeat in the protein. This variant did not segregate with the disease in the corresponding family and was also detected in 1/380 control subject. Our results suggest that UBQLN2 gene mutations are rare in French ALS. Copyright ÂEntities:
Mesh:
Substances:
Year: 2011 PMID: 22169395 DOI: 10.1016/j.neurobiolaging.2011.11.010
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673